Andere Sprachen Evolent Health, Inc.

Aktien

A14UCN

US30050B1017

EVH

Markt geschlossen - Nyse Andere Börsenplätze 22:00:02 10.05.2024			% 5 Tage	% 1. Jan.
24,46 ^USD	-9,27 %		-9,74 %	-25,95 %

20:26	EVOLENT HEALTH, INC. : erhält Kaufen-Rating von UBS	ZM
09.05.	Evolent Health Q1 bereinigtes Ergebnis, Umsatzanstieg; Umsatzprognose für Q2 festgelegt, Umsatzprognose für 2024 angehoben	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Evolent Health: Q1 Earnings Snapshot	09.05.
Evolent Health Q1 Adjusted Earnings, Revenue Rise; Q2 Revenue Guidance Set, 2024 Revenue Outlook Increased	09.05.
Earnings Flash (EVH) EVOLENT HEALTH Posts Q1 EPS $0.34, vs. Street Est of $0.30	09.05.
Earnings Flash (EVH) EVOLENT HEALTH Posts Q1 Revenue $639.7M, vs. Street Est of $598.9M	09.05.
Evolent and Careology form strategic care navigation partnership to enhance cancer care in the U.S.	09.05.
Evolent Announces First Quarter 2024 Results	09.05.
Evolent Health : 2024 Notice of Meeting and Proxy Statement	26.04.
Evolent Health : 2024 Proxy Card	26.04.
Evolent To Release First Quarter 2024 Financial Results on Thursday, May 9, 2024	18.04.
Evolent Health Q4 Adjusted Income, Revenue Rise; Q1, 2024 Revenue Guidance Set; Shares Jump After Hours	22.02.
Evolent Health: Q4 Earnings Snapshot	22.02.
Earnings Flash (EVH) EVOLENT HEALTH Reports Q4 EPS $0.23, vs. Street Est of $0.15	22.02.
Earnings Flash (EVH) EVOLENT HEALTH Posts Q4 Revenue $556.1M, vs. Street Est of $542.9M	22.02.
Evolent Announces Fourth Quarter and Full Year 2023 Results	22.02.
Evolent Health, Inc. Provides Earnings Guidance for the First Quarter Ending March 31, 2024 and Full Year Ending December 31, 2024	22.02.
Evolent Health, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	22.02.
Evolent Adds Russell Glass, Headspace CEO, to Board of Directors	14.02.
Evolent Health, Inc. Announces Board Changes	14.02.
Evolent to Release Fourth Quarter 2023 Financial Results on Thursday, February 22, 2024	25.01.
Evolent Health, Inc. Announces Pricing of $350.0 Million of Convertible Senior Notes Due 2029 to Pay Down Senior Term Loan	06.12.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Evolent Health, Inc.

Aktien

A14UCN

US30050B1017

EVH

Andere Sprachen

Filter